Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells

Molecules

Volumn 14, Issue 2, 2009, Pages 738-754

  Szliszka, Ewelina ^a   Czuba, Zenon P ^a   Domino, Maciej ^a   Mazur, Bogdan ^a   Zydowicz, Grzegorz ^a   Krol, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Antitumor activity; Apoptosis; Cancer cells; Chemopreventive effect; Propolis and its phenolic compounds; TRAIL

Indexed keywords

EID: 61449220943     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14020738     Document Type: Article

References (38)

1. World Health Organization: Cancer, 2006.
2. Birt, D.F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 2001, 90, 157-177.
3. Kwon, K.H.; Barve, A.; Yu, S.; Huang, M.; Kong, A.T. Cancer chemoprevention by phytochemicals: potencial molecular targets, biomarkers and animal models. Acta. Pharmacol. Sin. 2007, 28, 1409-1421.
4. Tsao, A.S.; Kim, E.S.; Hong, W.K. Chemoprevention of cancer. CA Cancer J. Clin. 2004, 54, 150-180.
5. Chen, L.; Zhang, H. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 2007, 12, 946-957.
6. Sporn, M.B.; Dunlop, N.M.; Newton, D.L.; Smith, J.M.; Prevention chemicals carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 1976, 35, 1332-1338.
7. Aso, K.; Kanno, S.; Tadano, T., Satoh, S.; Ishikawa, M. Inhibitory effect of propolis on the growth of human leukemia U937. Biol. Pharm. Bull. 2004, 27, 727-730.
8. Scheller, S.; Krol, W.; Swiacik, J.; Owczarek, S.; Gabrys, J.; Shani, J. Antitumoral property of ethanolic extract of propolis (EEP) in mice-bearing Ehrlich carcinoma. Z. Naturforsch. 1989, 44C, 1063-1065.
9. Orsolic, N.; Sver, L.; Terzic, S.; Basic, J. Peroral application of water-soluble derivate of propolis (WSPD) and its related polyphenolic compounds and their influence on immunological and antitumour activity. Vet. Res. Commun. 2005, 29, 575-593.
10. ·+ stable free radical assay. Molecules 2008, 12, 1006-1021.
11. Orsolic, N.; Terzic, S.; Mihaljevic, Z.; Sver, L.; Basic, J. Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. Biol. Pharm. Bull. 2005, 28, 1928-1933.
12. Orsolic, N.; Basic, J. Immunomodulation of water-soluble derivate of propolis: a factor of antitumor reactivity. Biol. Pharm. Bull. 2003, 84, 265-273.
13. Krol, W.; Scheller, S.; Czuba, Z.; Matsuno, T.; Zydowicz, G.; Shani, J.; Mos, M. Inhibition of neutrophils' chemiluminescence by ethanol extract of propolis (EEP) and its phenolic components. J. Ethnopharmacol. 1996, 55, 19-25.
14. Blonska, M.; Bronikowska, J.; Pietsz, G.; Czuba, Z.P.; Scheller, S.; Krol, W. Effects of ethanol extract of propolis (EEP) and its flavones on inducible gene expression in J774A.1 macrophages. J. Ethnopharmacol. 2004, 91, 25-30.
15. Sforcin, J.M. Propolis and the immune system: a review. J. Ethnopharmacol. 2007, 113, 1-14.
16. Almasan, A.; Ashkenazi, A. Apo2L/TRAIL: apoptosis signaling, biology and potential for cancer therapy. Cytokine Growth Factor Rev. 2003, 14, 337-348.
17. Zhang, L.; Fang, B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 2005, 12, 228-237.
18. Shankar, S.; Srivastava, R.K. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resist. Updat. 2004, 7, 139-156.
19. Szliszka, E.; Majcher, A.; Domino, M.; Pietsz, G.; Król, W. Cytotoxic activity of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) against bladder cancer cells after using chemotherapeutic drugs. Polish J. Urol. 2007, 60, 138-142.
20. Szliszka, E.; Czuba, Z.P.; Jernas, K., Krol, W. Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Int. J. Mol. Sci. 2008, 9, 56-64.
21. Bankova, V.S.; Popov, S.S.; Marekov, N.L. A study of flavonoids of propolis. J. Nat. Prod. 1983, 46, 471-474.
22. Czuba Z.P.; Krol W. The importance of hydroxyl substituent in position 4' in flavonoids for modulation of chemiluminescence generated by an enzymatic system (horseradish peroxidase - luminol - hydrogen peroxide). Curr. Top Biophys. 1996, 20S; 38-41.
23. Plochmann, K.; Korte, G.; Koutsilieri, E.; Richling, E.; Riederer, P.; Rethwilm, A.; Schreier, P.; Scheller, C. Structure - activity relationships of flavonoid - induced cytotoxicity on human leukemia cells. Arch. Biochem. Biophys. 2007, 460, 1-9.
24. Moridani, M.Y.; Galati, G.; O'Brien, P.J. Comparative quantitative structure toxicity relationships for flavonoids evaluated in isolated rat hepatocytes and HeLa tumor cells. Chem.-Biol. Interact. 2002, 139, 251-264.
25. Kim, D.O., Lee, C.Y. Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit. Rev. Food Sci. Nutr. 2004, 44, 253-273.
26. Ramos, S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 2007, 18, 427-442.
27. Horinaka, M.; Yoshida, T.; Shiraishi, T.; Nakata, S.; Wakada, M.; Nakanishi, R.; Nishino, H.; Sakai, T. The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells. Biochem. Biophys. Res. Commun. 2005, 333, 833-838.
28. Horinaka, M.; Yoshida, T.; Shiraishi, T.; Nakata, S.; Wakada, M.; Sakai, T. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol. Cancer Ther. 2006, 5, 945-951.
29. Yoshida, T.; Konishi, M.; Horinaka, M.; Yasuda, T.; Goda, A.E.; Taniguchi, H.; Yano, K.; Wakada, M.; Sakai, T. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem. Biophys. Res. Commun. 2008, 375, 129-133.
30. Kim, Y.H.; Lee, D.H.; Jeong, J.H.; Guo, Z.S.; Lee, Y.J. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem. Pharmacol. 2008, 75, 1946-1958.
31. Hsu, Y.L., Kuo, P.L., Lin, C.C. Acacetin inhibits the proliferation of Hep G2 by blocking cell cycle progression and inducing apoptosis. Biochem. Pharmacol. 2004, 67, 823-829.
32. Hsu, Y.L., Kuo, P.L., Liu, C.F., Lin, C.C. Acacetin-induced cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells. Cancer Lett. 2004, 212, 53-60.
33. Singh, R.P., Agrawal, P., Yim, D., Agarwal, C., Agarwal, R. Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate. Carcinogenesis 2005, 26, 845-854.
34. Pan, M.H., Lai, C.S., Hsu, P.C., Wang, Y.J. Acacetin induces apoptosis in human gastric carcinoma cells accompanied by activation of caspase cascades and production of reactive oxygen species. J. Agric. Food Chem. 2005, 53, 620-630.
35. Shim, H.Y., Park, J.H., Paik, H.D., Nah, S.Y., Kim, D.S., Han, Y.S. Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c-Jun activation. Mol. Cells 2007, 24, 95-104.
36. Cell proliferation kit I (MTT). Instruction manual, Version 3; Roche Applied Science: Germany, 2003.
37. Cytotoxicity detection kit (LDH). Instruction manual, Version 5; Roche Applied Science, Germany, 2004.
38. Ohtsuki, T.; Tamaki, M.; Tourne, K.; Ishibashi M. A novel sesquiterpenoid dimer parviflorene F induces apoptosis by up-regulating the expression of TRAIL-R2 and a caspase-dependent mechanism. Bioorg. Med Chem. 2008, 16, 1756-1763.